CTO at MBYS
Omar also serves as the CEO and Chief Portfolio Manager of Armitage Capital, a hedge fund focused on investing in biotechnology companies. Prior to this, he was a software developer at several large hedge funds focused on biotechnology investing, as well as Morgan Stanley’s Institutional Equities Division. He is also a biologist researching the Golgi under the advisory James Rothman, attempting to elucidate the structural mechanisms behind intra-Golgi protein trafficking. He was an early investor in the crypto space and continues to remain passionate about the space. He studied Computer Science, Physics and Economics at Yale University.